8th Annual Biomarkers Congress 2013

The Event

In keeping with Oxford Global’s highly successful life sciences series, an expert panel of over 50 speakers will present a full conference programme covering the topics outlined below:

8th Annual Biomarkers Congress

Day 1 Stream 1 –  Biomarker Discovery & Development

• Biomarker assays
• Open innovation initiatives
• Analytical methods & applications
• Biobanking
• Regulatory strategy
• Validation challenges

Day 1 Stream 2 – Companion Diagnostics & Personalised Medicine

• Patient selection
• Translating biomarkers into clinical diagnostics
• Rx/Dx co-development
• Biomarker based PHC
• Diagnostic imaging
• Prediction of treatment response

Day 2 Stream 1 – Biomarkers in Clinical Development

• Biomarkers as surrogate endpoints
• Circulating protein biomarkers
• Safety & toxicity biomarkers
• Biomarker integration
• PK/PD markers
• Clinical decision making

Day 2 Stream 2 – Enabling Technologies & Identification

• Reducing attrition rates
• Multiple reaction monitoring
• Systems pharmacology modelling
• Proteomics
• Genomics & epigenomics
• Metabolomics

2nd Annual CNS Biomarkers Congress

Day 1 –  CNS Biomarkers

• Monitoring therapeutic efficacy
• Human pain models
• Neurobehavioural markers
• Alzheimer’s disease
• Fragile X syndrome
• Autism

Day 2 – CNS Case Studies

• Neuroimaging
• Nuclear medicine
• Cognitive function markers
• Post traumatic stress disorder
• MS & ALS
• Schizophrenia

• Sameer Agarwal
  Senior Vice President, Business Center-Strategic Marketing IV Drugs, Fresenius Kabi
• Balaji Agoram
  Director Clinical Pharmacology and Pharmacokinetics, MedImmune
• Mads Almose Røpke
  Senior Scientist, LEO Pharma
• Khusru Asadullah
  VP and Head of Global Biomarkers, Bayer Health Care
• Till Bachmann
  Reader in Personalised Medicine in Infectious Diseases, Edinburgh University
• Anne-Christine Bay-Jensen
  Principal Scientist, Head of Rheumatology, Nordic Bioscience
• Christine Becker
  Head, Global Regulatory Affairs, Diagnostic Imaging,  Bayer
• Mark Broenstrup
  Section Head Biomarker & Diagnostics, Sanofi Aventis
• Miu Chau
  Global Head Companion Diagnostics Operations, Genentech
• Paul Cutler
  Head of Mass Spectrometry, Roche
• Andre De Costa
  Senior Scientist Safety Biomarkers, UCB
• Varsha Desai
  Research Biologist, FDA
• Lucette Doessegger
  Global Head Safety Licensing and Early Development, Roche
• Michael E. Burczynski
  Executive Director, Integrated Biomarker Technologies, Bristol-Myers Squibb
• Chris Harbron
  Senior Principal Statistician - Personalised Healthcare & Biomarkers, AstraZeneca
• John Haselden
  Director & Head of Investigative Preclinical Toxicology, Safety Assessment, GSK R&D
• Kim Henriksen
  Head of Neurodegenerative Diseases, Nordic Bioscience
• Michael Herschel
  Director Clinical Research, GSK
• Joerg Heyer
  Director Cancer Biology, AVEO Oncology
• Heinz Hänel
  Professor, Diabetes Division, Sanofi
• Marti Jett
  Director, Integrative Systems Biology, Chief Scientist, Systems Biology Enterprise US Army Medical Command (MEDCOM), US Army Center for Environmental Health Research
• Sajan Khosla
  Principal Informatics Scientist, AstraZeneca
• Gereon Lauer
  Associated Director Clinical Biomarkers, Vertex Pharmaceuticals (Europe) Ltd
• Afrodite Lourbakos
  Director Bioanalysis & Biomarkers, Prosensa
• Johan Luthman
  VP Neuroscience R&D, Franchise Integrator, Merck & Co
• Hugh Marston
  Head of Pharmacology, TPP Global Development Ltd
• Emilio Merlo Pich
  Head, CNS Biomarker & Clinical Imaging, F. Hoffmann-La Roche
• Mehdi Mesri
  Program Manager, NIH / National Cancer Institute
• Allison Nance
  Executive Director, Global Regulatory Affairs, Biomarkers/Diagnostics Development, Celgene Corporation
• Pradeep Nathan
  Professor and Director of Neuroscience, GlaxoSmithKline
• N R Nirmala
  Director, Biomarker Analysis and Informatics, Novartis Institutes for Biomedical Research
• Tim Peakman
  Deputy CEO, UK Biobank & UK Biocentre
• Darrel Pemberton
  Associate Director, Neuroscience Early Development, Janssen
• Stephen Pennington
  Professor of Proteomics, School of Medicine and Medical Science, UCD Conway Institute, University College Dublin
• Mark Pinches
  Biomarker Lead, Global Safety Assessment, AstraZeneca
• Andrew Pitt
  Professor of Pharmaceutical Chemistry and Chemical Biology, Aston University
• Jens Rengelshausen
  Head Translational Medicine Global Early Clinical Development, Grünenthal
• Senior Representative
  Prosensa
• Sally-Ann Ricketts
  Director, In Vivo Biomarkers, AstraZeneca
• Anthony Rowe
  Principal Research Scientist, Janssen Research and Development
• Gemma Satterthwaite
  Director & Portfolio Lead, Personalised Healthcare and Biomarkers, Astrazeneca
• Robert Schupp
  Executive Director Diagnostics Hematology/Oncology, Celgene
• Kresten Skak
  Head of Section, LEO Pharma
• Holly Soares
  Director Clinical Biomarkers Neruoscience, BMS
• Corinne Solier
  Group Head, Clinical Protein Biomarkers, Roche Pharma
• Hans Ulrichts
  Section Head Pharmacology – Pharmacodynamics and Translational Medicine, Ablynx
• Alain Van Gool
  Head Biomarkers in Personalized Medicine, TNO
• Eduardo Vianna
  Clinical Scientist, Roche
• Anne Vogt
  Personalized Health Care Leader, Neuroscience, Roche
• Richardus Vonk
  Head of Global Drug Discovery Statistics and Experimental Medicine Statistics, Bayer Pharma AG
• Jill Walker
  Diagnostics Director, AstraZeneca
• Susan Ward
  Sr. Clinical Program Lead, Translational and Experimental Medicine, Biogen
• Andy West
  Biological Mass Spectrometry Section Head, GSK
• Hans Westerhoff
  AstraZeneca Chair for Systems Biology, Professor of Synthetic Systems Biology, University of Amsterdam and University of Manchester
• Paul Whittaker
  Director/Unit Head for Pre-Clinical Biomarkers, Respiratory Disease Area, Novartis
• Sophie Wildsmith
  Biomarker Key Service Area Manager, Strategic Outsourcing, Roche
• Doris-Ann Williams MBE
  Director-General, British In Vitro Diagnostics Association
• John Wise
  Executive Director, Pistoia Alliance

Registration is due to close. Book now at: http://ds4.delegateselect.co.uk/MT/Run/event/main.html?EC=147062&EEID=337865733793565136239212255&EGID=74152026904&override=shownewreg